TELA Bio TELA
NASDAQ TELA
$0.85 -0.06 (-6.40%)
As of: Sep 10, 2026 · 1:18 PM EDT

TELA Bio (TELA) Net Income Growth (5y) (2023 - 2026)

Analysis

TELA Bio (TELA) Net Income Growth (5y) (2023 - 2026) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Abbott Laboratories 180.74 Bn 175.14 Bn 7.27 Bn
2 Intuitive Surgical 127.56 Bn 122.34 Bn 1.96 Bn
3 Medtronic 116.90 Bn 108.08 Bn 6.34 Bn
4 Stryker 103.85 Bn 100.37 Bn 4.50 Bn
5 Boston Scientific 63.70 Bn 63.16 Bn 3.85 Bn
6 Edwards Lifesciences 49.88 Bn 45.63 Bn 1.35 Bn
7 Alcon 33.04 Bn 31.59 Bn 1.68 Bn
8 Dexcom 32.18 Bn 30.23 Bn 830.00 Mn
9 Steris 20.65 Bn 20.17 Bn 684.20 Mn
10 TELA Bio 48.87 Mn 18.44 Mn 13.94 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -6.62%
Mar 31, 2026 -8.51%
Dec 31, 2025 30.26%
Sep 30, 2025 -2.08%
Jun 30, 2025 -10.40%
Mar 31, 2025 -8.83%
Dec 31, 2024 -8.24%
Sep 30, 2024 -16.88%
Jun 30, 2024 -19.30%
Mar 31, 2024 1.46%
Dec 31, 2023 -16.81%
Sep 30, 2023 -32.37%